Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics

Alnylam Pharmaceuticals (ALNY) reported $494.33 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 54.8$0.16 for the same period compares to -$1.40 a year ago.The reported revenue represents a surprise of +17.39$421.1 million. With the consensus EPS estimate being -$0.75, the EPS surprise was +78.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they com ...